Anti-folate receptor alpha IgE antibody (IGEM Therapeutics)

N/A

Report date: 2022/07/18 17:41:19

Base Information

Drug NameAnti-folate receptor alpha IgE antibody (IGEM Therapeutics)
Drug Alias NameMOv18 IgE
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionFolate receptor alpha antagonists
TargetsFolate receptor alpha
Therapy Area/IndicationsLung NeoplasmsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKing'S College LondonEpsilogen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKing'S College London
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A